News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
753,786 Results
Type
Article (46245)
Company Profile (322)
Press Release (707199)
Multimedia
Podcasts (92)
Webinars (23)
Section
Business (211534)
Career Advice (2200)
Deals (36506)
Drug Delivery (132)
Drug Development (83330)
Employer Resources (176)
FDA (17034)
Job Trends (15599)
News (357601)
Policy (34160)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2773)
Academic (1)
Accelerated approval (42)
Adcomms (28)
Allergies (165)
Alliances (51942)
ALS (196)
Alzheimer's disease (1799)
Antibody-drug conjugate (ADC) (383)
Approvals (17337)
Artificial intelligence (622)
Autoimmune disease (226)
Automation (53)
Bankruptcy (373)
Best Places to Work (12071)
BIOSECURE Act (20)
Biosimilars (207)
Biotechnology (204)
Bladder cancer (178)
Brain cancer (66)
Breast cancer (698)
Cancer (5440)
Cardiovascular disease (464)
Career advice (1867)
Career pathing (43)
CAR-T (316)
CDC (56)
Celiac Disease (2)
Cell therapy (841)
Cervical cancer (43)
Clinical research (71536)
Collaboration (1991)
Company closure (5)
Compensation (1285)
Complete response letters (77)
COVID-19 (2876)
CRISPR (106)
C-suite (1026)
Cystic fibrosis (152)
Data (7141)
Decentralized trials (3)
Denatured (29)
Depression (156)
Dermatology (57)
Diabetes (558)
Diagnostics (7139)
Digital health (54)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (307)
Drug pricing (203)
Drug shortages (29)
Duchenne muscular dystrophy (277)
Earnings (92660)
Editorial (64)
Employer branding (22)
Employer resources (155)
Events (122520)
Executive appointments (1090)
FDA (20525)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1676)
Gene editing (225)
Generative AI (54)
Gene therapy (698)
GLP-1 (1058)
Government (4909)
Grass and pollen (7)
Guidances (398)
Healthcare (19678)
HIV (76)
Huntington's disease (52)
IgA nephropathy (92)
Immunology and inflammation (283)
Immuno-oncology (85)
Indications (157)
Infectious disease (3201)
Inflammatory bowel disease (205)
Inflation Reduction Act (14)
Influenza (133)
Intellectual property (280)
Interviews (349)
IPO (16957)
IRA (52)
Job creations (3860)
Job search strategy (1553)
JPM (63)
Kidney cancer (18)
Labor market (93)
Layoffs (581)
Leadership (38)
Legal (8323)
Liver cancer (101)
Longevity (28)
Lung cancer (729)
Lymphoma (411)
Machine learning (52)
Management (60)
Manufacturing (953)
MASH (181)
Medical device (14370)
Medtech (14451)
Mergers & acquisitions (20730)
Metabolic disorders (1434)
mRNA (192)
Multiple sclerosis (175)
NASH (18)
Neurodegenerative disease (400)
Neuropsychiatric disorders (101)
Neuroscience (3226)
Neurotech (1)
NextGen: Class of 2026 (6852)
Non-profit (4743)
Now hiring (73)
Obesity (672)
Opinion (298)
Ovarian cancer (187)
Pain (234)
Pancreatic cancer (260)
Parkinson's disease (345)
Partnered (35)
Patents (566)
Patient recruitment (605)
Peanut (61)
People (61478)
Pharmaceutical (67)
Pharmacy benefit managers (32)
Phase 1 (22363)
Phase 2 (31448)
Phase 3 (23473)
Pipeline (7224)
Policy (311)
Postmarket research (2639)
Preclinical (9572)
Press Release (68)
Prostate cancer (281)
Psychedelics (51)
Radiopharmaceuticals (320)
Rare diseases (1039)
Real estate (6299)
Recruiting (70)
Regulatory (25961)
Reports (55)
Research institute (2549)
Resumes & cover letters (372)
Rett syndrome (32)
RNA editing (19)
RSV (86)
Schizophrenia (169)
Series A (280)
Series B (207)
Service/supplier (14)
Sickle cell disease (111)
Special edition (23)
Spinal muscular atrophy (169)
Sponsored (49)
Startups (3775)
State (2)
Stomach cancer (18)
Supply chain (122)
Tariffs (90)
The Weekly (60)
Vaccines (1108)
Venture capital (106)
Weight loss (432)
Women's health (109)
Worklife (20)
Date
Last 7 days (655)
Last 30 days (2590)
Last 365 days (30800)
2026 (8224)
2025 (31105)
2024 (36182)
2023 (41155)
2022 (52355)
2021 (56993)
2020 (55622)
2019 (48479)
2018 (36572)
2017 (33403)
2016 (32872)
2015 (38926)
2014 (32744)
2013 (27854)
2012 (29973)
2011 (30574)
2010 (28582)
Location
Africa (788)
Alabama (93)
Alaska (7)
Arizona (341)
Arkansas (14)
Asia (41524)
Australia (6915)
California (12488)
Canada (3543)
China (1264)
Colorado (531)
Connecticut (544)
Delaware (373)
Europe (91819)
Florida (1863)
Georgia (405)
Hawaii (3)
Idaho (64)
Illinois (994)
India (85)
Indiana (571)
Iowa (23)
Japan (497)
Kansas (132)
Kentucky (46)
Louisiana (38)
Maine (73)
Maryland (1524)
Massachusetts (8958)
Michigan (369)
Minnesota (694)
Mississippi (7)
Missouri (150)
Montana (37)
Nebraska (29)
Nevada (141)
New Hampshire (88)
New Jersey (3348)
New Mexico (30)
New York (3291)
North Carolina (1631)
North Dakota (10)
Northern California (6142)
Ohio (378)
Oklahoma (24)
Oregon (43)
Pennsylvania (2515)
Puerto Rico (26)
Rhode Island (50)
South America (1186)
South Carolina (78)
South Dakota (1)
Southern California (4917)
Tennessee (201)
Texas (1979)
United States (44408)
Utah (375)
Vermont (1)
Virginia (299)
Washington D.C. (81)
Washington State (996)
West Virginia (4)
Wisconsin (124)
Wyoming (2)
753,786 Results for "del laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BrYet US, Inc. Expands Patent Portfolio with New U.S. Patent for Targeted Drug Delivery
Near-term applications include combinations with kinase inhibitors (KIs) that achieve enhanced concentration at target sites and synergistic delivery of multiple KIs to the same location
November 13, 2025
·
1 min read
Press Releases
Sionna Therapeutics Announces Presentation of SION-719 and SION-451 Phase 1 Data and Poster of New Preclinical Data on the Impact of NBD1 Stabilizers on F508del-CFTR Half-Life at the 2025 North American Cystic Fibrosis Conference
October 27, 2025
·
7 min read
Press Releases
Avidity Biosciences’ Del-zota Demonstrated Reversal of Disease Progression Across Key Functional Endpoints in EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Trial in People Living with DMD44
September 10, 2025
·
14 min read
Press Releases
Avidity Biosciences Receives FDA Breakthrough Therapy Designation for Delpacibart Zotadirsen (del-zota) for the Treatment of DMD in People with Mutations Amenable to Exon 44 Skipping
July 23, 2025
·
10 min read
Press Releases
Longevity Medical Institute® Opens Federally Licensed Stem Cell and Regenerative Medicine Biotechnology Laboratory in Los Cabos
March 4, 2026
·
4 min read
Press Releases
NexCure, Inc. Launches with $19 Million Series A Financing to enable CAR-T and other advanced treatment delivery in community outpatient settings
March 5, 2026
·
6 min read
Press Releases
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025
October 5, 2025
·
1 min read
Press Releases
Charles River Laboratories Provides Update on Planned Divestitures
February 25, 2026
·
9 min read
Press Releases
Avidity Biosciences Announces Completion of Enrollment for HARBOR™, the First Global Phase 3 Trial of Delpacibart Etedesiran (del-desiran) for Treatment of DM1 and Provides Guidance on Regulatory Submission
July 28, 2025
·
8 min read
Press Releases
Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO
March 9, 2026
·
3 min read
Previous
2 of 75,379
Next
